Cost effectiveness of treatments for relapsed/refractory multiple myeloma: response to a methodology. RE: Hornberger J, Rickert J, Dhawan R, Liwing J, Aschan J, Löthgren M. The cost effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective. European Journal of Haematology 2010; 85 (6):484-491. [electronic resource]

By: Contributor(s): Producer: 20110824Description: 95; author reply 96-7 p. digitalISSN:
  • 1600-0609
Subject(s): Online resources: In: European journal of haematology vol. 87
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Comment

There are no comments on this title.

to post a comment.